[1]
“IN SILICO STUDY OF VANILLIN SCHIFF BASES AS PROTO ONCOGENE TYROSINE KINASE INHIBITORS OF CHRONIC MYELOID LEUKEMIA”, FMHR, vol. 3, no. 10, pp. 570–577, Dec. 2025, Accessed: Nov. 10, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/1765